Hepatitis C virus re ‐treatment in the era of direct‐acting antivirals: projections in the USA

ConclusionsEven in the era of highly effective DAAs, a significant number of patients will fail to achieve SVR and will require re‐treatment options. Timely and effective re‐treatment is essential to prevent the long‐term sequelae of HCV.

Source: Alimentary Pharmacology and Therapeutics - January 29, 2018 Category: Drugs & Pharmacology Authors: J. Chhatwal, Q. Chen, T. Ayer, E. D. Bethea, F. Kanwal, K. V. Kowdley, X. Wang, M. S. Roberts, S. C. Gordon Tags: ORIGINAL ARTICLE Source Type: research